Next-Generation Sequencing-Based Panel Testing for Myeloid Neoplasms

被引：0
作者：
Frank C. Kuo
Fei Dong
机构：
[1] Brigham and Women’s Hospital,Center for Advanced Molecular Diagnostics, Department of Pathology
[2] Harvard Medical School,undefined
来源：
Current Hematologic Malignancy Reports | 2015年 / 10卷
关键词：
Next-generation sequencing; Myeloid neoplasm; Acute myeloid leukemia; Myelodysplastic syndromes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Our ability to interrogate a broad array of genetic alterations in myeloid neoplasm has increased significantly with the advance in next-generation sequencing (NGS). In addition to morphologic examination, flow cytometry, and cytogenetics, NGS-based testing can add additional information to the diagnostic workup. More than a dozen myeloid-focused NGS-based panels are now available from commercial and academic laboratories. In this review, we examine the content of these panels in the context of our current understanding of driver alterations in myeloid neoplasms. With improved turnaround time, decreasing costs, and an expanding knowledge of the therapeutic and prognostic significance of the detected variants, NGS-based panel testing is likely to play a major role in the management of patients with myeloid neoplasm in the coming decade.
引用
收藏
页码：104 / 111
页数：7
相关论文
共 362 条
[1]  
Bonnet D(1997)Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 730-7
[2]  
Dick JE(2006)Bone-marrow haematopoietic-stem-cell niches Nat Rev Immunol 6 93-106
[3]  
Wilson A(2014)Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia Nature 506 328-33
[4]  
Trumpp A(2013)Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia N Engl J Med 368 2059-74
[5]  
Shlush LI(2013)The beginning of the end of the beginning in cancer genomics N Engl J Med 368 2138-40
[6]  
Zandi S(2012)Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia Mod Pathol 25 795-804
[7]  
Mitchell A(2005)Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations Blood 106 3740-6
[8]  
Chen WC(2006)Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML) Blood 107 4011-20
[9]  
Brandwein JM(2005)Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype N Engl J Med 352 254-66
[10]  
Gupta V(1996)Internal tandem duplication of the flt3 gene found in acute myeloid leukemia Leukemia 10 1911-8
12345678910